 | • レポートコード：QFJ1-5795 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、イバンドロン酸の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・イバンドロン酸の市場動向 ・企業の競争状況、市場シェア ・イバンドロン酸の種類別市場規模と予測2016-2027（経口、注射） ・イバンドロン酸の用途別市場規模と予測2016-2027（病院、ドラッグストア） ・イバンドロン酸の北米市場規模2016-2027（アメリカ、カナダ） ・イバンドロン酸の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・イバンドロン酸のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・イバンドロン酸の中南米市場規模2016-2027（メキシコ、ブラジル） ・イバンドロン酸の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、Apotex、Mylan、Sun Pharmaceutical、Dr Reddy's Laboratories、Aurobindo Pharma、MACLEODS） ・結論 |
Ibandronate is prescription medication used for treating osteoporosis in women after menopause.
Market Analysis and Insights: Global Ibandronate Market
The global Ibandronate market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ibandronate market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ibandronate market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ibandronate market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ibandronate market.
Global Ibandronate Scope and Market Size
Ibandronate market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ibandronate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Oral
Injection
Segment by Application
Hospital
Drug store
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Roche
Apotex
Mylan
Sun Pharmaceutical
Dr Reddy’s Laboratories
Aurobindo Pharma
MACLEODS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ibandronate Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Ibandronate Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Drug store
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Ibandronate Market Perspective (2016-2027)
2.2 Ibandronate Growth Trends by Regions
2.2.1 Ibandronate Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Ibandronate Historic Market Share by Regions (2016-2021)
2.2.3 Ibandronate Forecasted Market Size by Regions (2022-2027)
2.3 Ibandronate Industry Dynamic
2.3.1 Ibandronate Market Trends
2.3.2 Ibandronate Market Drivers
2.3.3 Ibandronate Market Challenges
2.3.4 Ibandronate Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ibandronate Players by Revenue
3.1.1 Global Top Ibandronate Players by Revenue (2016-2021)
3.1.2 Global Ibandronate Revenue Market Share by Players (2016-2021)
3.2 Global Ibandronate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Ibandronate Revenue
3.4 Global Ibandronate Market Concentration Ratio
3.4.1 Global Ibandronate Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ibandronate Revenue in 2020
3.5 Ibandronate Key Players Head office and Area Served
3.6 Key Players Ibandronate Product Solution and Service
3.7 Date of Enter into Ibandronate Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Ibandronate Breakdown Data by Type
4.1 Global Ibandronate Historic Market Size by Type (2016-2021)
4.2 Global Ibandronate Forecasted Market Size by Type (2022-2027)
5 Ibandronate Breakdown Data by Application
5.1 Global Ibandronate Historic Market Size by Application (2016-2021)
5.2 Global Ibandronate Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Ibandronate Market Size (2016-2027)
6.2 North America Ibandronate Market Size by Type
6.2.1 North America Ibandronate Market Size by Type (2016-2021)
6.2.2 North America Ibandronate Market Size by Type (2022-2027)
6.2.3 North America Ibandronate Market Size by Type (2016-2027)
6.3 North America Ibandronate Market Size by Application
6.3.1 North America Ibandronate Market Size by Application (2016-2021)
6.3.2 North America Ibandronate Market Size by Application (2022-2027)
6.3.3 North America Ibandronate Market Size by Application (2016-2027)
6.4 North America Ibandronate Market Size by Country
6.4.1 North America Ibandronate Market Size by Country (2016-2021)
6.4.2 North America Ibandronate Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Ibandronate Market Size (2016-2027)
7.2 Europe Ibandronate Market Size by Type
7.2.1 Europe Ibandronate Market Size by Type (2016-2021)
7.2.2 Europe Ibandronate Market Size by Type (2022-2027)
7.2.3 Europe Ibandronate Market Size by Type (2016-2027)
7.3 Europe Ibandronate Market Size by Application
7.3.1 Europe Ibandronate Market Size by Application (2016-2021)
7.3.2 Europe Ibandronate Market Size by Application (2022-2027)
7.3.3 Europe Ibandronate Market Size by Application (2016-2027)
7.4 Europe Ibandronate Market Size by Country
7.4.1 Europe Ibandronate Market Size by Country (2016-2021)
7.4.2 Europe Ibandronate Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Ibandronate Market Size (2016-2027)
8.2 Asia-Pacific Ibandronate Market Size by Type
8.2.1 Asia-Pacific Ibandronate Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Ibandronate Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Ibandronate Market Size by Type (2016-2027)
8.3 Asia-Pacific Ibandronate Market Size by Application
8.3.1 Asia-Pacific Ibandronate Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Ibandronate Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Ibandronate Market Size by Application (2016-2027)
8.4 Asia-Pacific Ibandronate Market Size by Region
8.4.1 Asia-Pacific Ibandronate Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Ibandronate Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Ibandronate Market Size (2016-2027)
9.2 Latin America Ibandronate Market Size by Type
9.2.1 Latin America Ibandronate Market Size by Type (2016-2021)
9.2.2 Latin America Ibandronate Market Size by Type (2022-2027)
9.2.3 Latin America Ibandronate Market Size by Type (2016-2027)
9.3 Latin America Ibandronate Market Size by Application
9.3.1 Latin America Ibandronate Market Size by Application (2016-2021)
9.3.2 Latin America Ibandronate Market Size by Application (2022-2027)
9.3.3 Latin America Ibandronate Market Size by Application (2016-2027)
9.4 Latin America Ibandronate Market Size by Country
9.4.1 Latin America Ibandronate Market Size by Country (2016-2021)
9.4.2 Latin America Ibandronate Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ibandronate Market Size (2016-2027)
10.2 Middle East & Africa Ibandronate Market Size by Type
10.2.1 Middle East & Africa Ibandronate Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Ibandronate Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Ibandronate Market Size by Type (2016-2027)
10.3 Middle East & Africa Ibandronate Market Size by Application
10.3.1 Middle East & Africa Ibandronate Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Ibandronate Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Ibandronate Market Size by Application (2016-2027)
10.4 Middle East & Africa Ibandronate Market Size by Country
10.4.1 Middle East & Africa Ibandronate Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Ibandronate Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Ibandronate Introduction
11.1.4 Roche Revenue in Ibandronate Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Apotex
11.2.1 Apotex Company Details
11.2.2 Apotex Business Overview
11.2.3 Apotex Ibandronate Introduction
11.2.4 Apotex Revenue in Ibandronate Business (2016-2021)
11.2.5 Apotex Recent Development
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Ibandronate Introduction
11.3.4 Mylan Revenue in Ibandronate Business (2016-2021)
11.3.5 Mylan Recent Development
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Company Details
11.4.2 Sun Pharmaceutical Business Overview
11.4.3 Sun Pharmaceutical Ibandronate Introduction
11.4.4 Sun Pharmaceutical Revenue in Ibandronate Business (2016-2021)
11.4.5 Sun Pharmaceutical Recent Development
11.5 Dr Reddy’s Laboratories
11.5.1 Dr Reddy’s Laboratories Company Details
11.5.2 Dr Reddy’s Laboratories Business Overview
11.5.3 Dr Reddy’s Laboratories Ibandronate Introduction
11.5.4 Dr Reddy’s Laboratories Revenue in Ibandronate Business (2016-2021)
11.5.5 Dr Reddy’s Laboratories Recent Development
11.6 Aurobindo Pharma
11.6.1 Aurobindo Pharma Company Details
11.6.2 Aurobindo Pharma Business Overview
11.6.3 Aurobindo Pharma Ibandronate Introduction
11.6.4 Aurobindo Pharma Revenue in Ibandronate Business (2016-2021)
11.6.5 Aurobindo Pharma Recent Development
11.7 MACLEODS
11.7.1 MACLEODS Company Details
11.7.2 MACLEODS Business Overview
11.7.3 MACLEODS Ibandronate Introduction
11.7.4 MACLEODS Revenue in Ibandronate Business (2016-2021)
11.7.5 MACLEODS Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Ibandronate Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Global Ibandronate Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Ibandronate Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Ibandronate Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Ibandronate Market Share by Regions (2016-2021)
Table 8. Global Ibandronate Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Ibandronate Market Share by Regions (2022-2027)
Table 10. Ibandronate Market Trends
Table 11. Ibandronate Market Drivers
Table 12. Ibandronate Market Challenges
Table 13. Ibandronate Market Restraints
Table 14. Global Ibandronate Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Ibandronate Market Share by Players (2016-2021)
Table 16. Global Top Ibandronate Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ibandronate as of 2020)
Table 17. Ranking of Global Top Ibandronate Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Ibandronate Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Ibandronate Product Solution and Service
Table 21. Date of Enter into Ibandronate Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Ibandronate Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Ibandronate Revenue Market Share by Type (2016-2021)
Table 25. Global Ibandronate Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Ibandronate Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Ibandronate Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Ibandronate Revenue Market Share by Application (2016-2021)
Table 29. Global Ibandronate Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Ibandronate Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Ibandronate Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Ibandronate Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Ibandronate Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Ibandronate Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Ibandronate Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Ibandronate Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Ibandronate Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Ibandronate Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Ibandronate Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Ibandronate Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Ibandronate Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Ibandronate Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Ibandronate Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Ibandronate Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Ibandronate Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Ibandronate Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Ibandronate Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Ibandronate Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Ibandronate Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Ibandronate Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Ibandronate Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Ibandronate Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Ibandronate Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Ibandronate Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Ibandronate Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Ibandronate Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Ibandronate Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Ibandronate Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Ibandronate Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Ibandronate Market Size by Country (2022-2027) & (US$ Million)
Table 61. Roche Company Details
Table 62. Roche Business Overview
Table 63. Roche Ibandronate Product
Table 64. Roche Revenue in Ibandronate Business (2016-2021) & (US$ Million)
Table 65. Roche Recent Development
Table 66. Apotex Company Details
Table 67. Apotex Business Overview
Table 68. Apotex Ibandronate Product
Table 69. Apotex Revenue in Ibandronate Business (2016-2021) & (US$ Million)
Table 70. Apotex Recent Development
Table 71. Mylan Company Details
Table 72. Mylan Business Overview
Table 73. Mylan Ibandronate Product
Table 74. Mylan Revenue in Ibandronate Business (2016-2021) & (US$ Million)
Table 75. Mylan Recent Development
Table 76. Sun Pharmaceutical Company Details
Table 77. Sun Pharmaceutical Business Overview
Table 78. Sun Pharmaceutical Ibandronate Product
Table 79. Sun Pharmaceutical Revenue in Ibandronate Business (2016-2021) & (US$ Million)
Table 80. Sun Pharmaceutical Recent Development
Table 81. Dr Reddy's Laboratories Company Details
Table 82. Dr Reddy's Laboratories Business Overview
Table 83. Dr Reddy's Laboratories Ibandronate Product
Table 84. Dr Reddy's Laboratories Revenue in Ibandronate Business (2016-2021) & (US$ Million)
Table 85. Dr Reddy's Laboratories Recent Development
Table 86. Aurobindo Pharma Company Details
Table 87. Aurobindo Pharma Business Overview
Table 88. Aurobindo Pharma Ibandronate Product
Table 89. Aurobindo Pharma Revenue in Ibandronate Business (2016-2021) & (US$ Million)
Table 90. Aurobindo Pharma Recent Development
Table 91. MACLEODS Company Details
Table 92. MACLEODS Business Overview
Table 93. MACLEODS Ibandronate Product
Table 94. MACLEODS Revenue in Ibandronate Business (2016-2021) & (US$ Million)
Table 95. MACLEODS Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ibandronate Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Injection Features
Figure 4. Global Ibandronate Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Drug store Case Studies
Figure 7. Ibandronate Report Years Considered
Figure 8. Global Ibandronate Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Ibandronate Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Ibandronate Market Share by Regions: 2020 VS 2027
Figure 11. Global Ibandronate Market Share by Regions (2022-2027)
Figure 12. Global Ibandronate Market Share by Players in 2020
Figure 13. Global Top Ibandronate Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ibandronate as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Ibandronate Revenue in 2020
Figure 15. Global Ibandronate Revenue Market Share by Type (2016-2021)
Figure 16. Global Ibandronate Revenue Market Share by Type (2022-2027)
Figure 17. North America Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Ibandronate Market Share by Type (2016-2027)
Figure 19. North America Ibandronate Market Share by Application (2016-2027)
Figure 20. North America Ibandronate Market Share by Country (2016-2027)
Figure 21. United States Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Ibandronate Market Share by Type (2016-2027)
Figure 25. Europe Ibandronate Market Share by Application (2016-2027)
Figure 26. Europe Ibandronate Market Share by Country (2016-2027)
Figure 27. Germany Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Ibandronate Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Ibandronate Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Ibandronate Market Share by Region (2016-2027)
Figure 37. China Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Ibandronate Market Share by Type (2016-2027)
Figure 45. Latin America Ibandronate Market Share by Application (2016-2027)
Figure 46. Latin America Ibandronate Market Share by Country (2016-2027)
Figure 47. Mexico Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Ibandronate Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Ibandronate Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Ibandronate Market Share by Country (2016-2027)
Figure 53. Turkey Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Roche Revenue Growth Rate in Ibandronate Business (2016-2021)
Figure 57. Apotex Revenue Growth Rate in Ibandronate Business (2016-2021)
Figure 58. Mylan Revenue Growth Rate in Ibandronate Business (2016-2021)
Figure 59. Sun Pharmaceutical Revenue Growth Rate in Ibandronate Business (2016-2021)
Figure 60. Dr Reddy's Laboratories Revenue Growth Rate in Ibandronate Business (2016-2021)
Figure 61. Aurobindo Pharma Revenue Growth Rate in Ibandronate Business (2016-2021)
Figure 62. MACLEODS Revenue Growth Rate in Ibandronate Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
世界のアンブリセンタン薬市場規模・現状・予測（2021年-2027年） Ambrisentan (U.S. trade name Letairis; E.U. trade name Volibris; India trade name Pulmonext by MSN labs) is a drug indicated for use in the treatment of pulmonary hypertension. Market Analysis and Insights: Global Ambrisentan Drug Market The global Ambrisentan Drug market size is projected to reach …- 世界の口腔がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing oral cancer Market Analysis and Insights: Global Oral Cancer Molecular Diagnosis Market The global Oral Cancer Molecular Diagnosis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With indust…
- 世界の抗コリン薬市場規模・現状・予測（2021年-2027年） Anticholinergic drugs are used to restrict the acetylcholine-provoked neurotransmission in different parts of the body including heart, peripheral nervous system, and other parts. Acetylcholine controls the involuntary functions such as salivation, sweating, digestion, and several others. The drug i…
- 世界のオーラルリンス市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Oral Rinse Market The global Oral Rinse market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant att…
- 世界の子宮ポリープ治療薬市場規模・現状・予測（2021年-2027年） Uterine polyps are common gynecological diseases. Broadly speaking, it refers to all tumors attached to the uterine wall by slender pedicle. Mostly benign. Market Analysis and Insights: Global Uterine Polyps Drug Market The global Uterine Polyps Drug market size is projected to reach US$ XX million …